This trial is testing whether two different ways of providing information to people considering genetic testing for cancer risk affects how likely they are to get the test.
1 Primary · 9 Secondary · Reporting Duration: Up to 3 years
220 Total Participants · 2 Treatment Groups
Primary Treatment: Educational Video · No Placebo Group · N/A
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: